TISLELIZUMAB for Adenocarcinoma gastric: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 99 adverse event reports in the FDA FAERS database where TISLELIZUMAB was used for Adenocarcinoma gastric.

Most Reported Side Effects for TISLELIZUMAB

Side Effect	Reports	%	Deaths	Hosp.
Myelosuppression	2,142	42.9%	5	1,052
White blood cell count decreased	327	6.6%	5	151
Neutrophil count decreased	277	5.5%	4	112
Hepatic function abnormal	221	4.4%	1	144
Pruritus	213	4.3%	1	101
Rash	208	4.2%	3	89
Platelet count decreased	183	3.7%	10	101
Pyrexia	175	3.5%	3	117
Nausea	165	3.3%	5	72
Diarrhoea	145	2.9%	6	87
Liver injury	139	2.8%	2	76
Decreased appetite	133	2.7%	3	72
Off label use	130	2.6%	11	51
Asthenia	125	2.5%	0	73
Anaemia	119	2.4%	4	33